Keynote speaker

Becca Senter

Chief Scientific Officer, Vertero Therapeutics

Conferences: 1
Keynotes: 1
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

10th MASH Drug Development Summit 2026Keynote speaker
15–17 Sept 2026Boston, United States of America
- KeynoteTargeting Bile Salt Hydrolase with the Oral Small Molecule VT-6382 as a Novel and Differentiated Approach to Treating MASH and Liver Fibrosis

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Becca Senter, and it lists only the talks, sessions and presentations named in those programmes.